Literature DB >> 19395866

Immune approaches to treating osteosarcoma.

Neyssa Marina1, Richard Gorlick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19395866     DOI： 10.4161/cbt.8.10.8602

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  3 in total

1.  Invariant NKT cells increase drug-induced osteosarcoma cell death.

Authors:  S Fallarini; T Paoletti; N Orsi Battaglini; G Lombardi
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 2.  Potential of human γδ T cells for immunotherapy of osteosarcoma.

Authors:  Zhaoxu Li
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

3.  p38 MAPK regulates the expression of ether à go-go potassium channel in human osteosarcoma cells.

Authors:  Xinyu Wu; Daixing Zhong; Bin Lin; Wenliang Zhai; Zhenqi Ding; Jin Wu
Journal:  Radiol Oncol       Date:  2013-02-01       Impact factor: 2.991
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.